Fundraising FoxBraidwell — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Caris Lifesciences operates a precision oncology platform that analyzes DNA, RNA and proteins across tissue and blood to profile a patient's cancer and match treatments and clinical trials.
AI & Machine LearningBiotechHealthtech
David Dean Halbert(Chairman, Founder and CEO)
Co-investorsCoatue ManagementSilver Lake PartnersSixth StreetMillennium ManagementOrbiMed
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)inPaul Bae(Chief Administrative Officer and General Counsel)inDavid Prutchi(Executive Vice President, Chief Technology Officer)inRichard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)in
Co-investorsAmzak HealthAlgerEssex Woodlands Healthcare PartnersREDMILESands Capital VenturesSignet Healthcare Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.